VSee Health 2025 10-K: Revenue $14.6M, Loss per Share $(0.73)

robot
Abstract generation in progress

VSee Health reported 2025 revenue of $14.62 million, a 40% increase attributed to the iDoc acquisition and higher telehealth volume. The company saw a net loss of $(14.74) million and a loss per share of $(0.73), an improvement from the prior year due to the absence of a goodwill impairment charge. Gross margin slightly increased to $7.36 million, and the company expanded its telecritical care, VSee Lab SaaS subscriptions, and professional EEG services.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin